Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:46:47.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Locations section expanded with numerous new sites across multiple countries and regions, while many existing sites were removed, altering geographic coverage of the trial.
    Difference
    3%
    Check dated 2025-12-23T21:17:19.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Publications section updated to clarify PubMed auto-fill and the revision tag updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T11:16:10.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the page has been removed. It previously stated that the NIH Clinical Center is open and provided links to operating status updates.
    Difference
    0.1%
    Check dated 2025-11-18T07:10:28.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added two Taiwan sites in Tainan (704 and 736) and removed the corresponding Tainan City entries (704 and 736) from the Locations section.
    Difference
    0.0%
    Check dated 2025-11-11T02:53:47.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The changes are limited to administrative updates such as the last updated date and minor formatting; there are no changes to core study information like eligibility criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:11:04.000Z thumbnail image

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.